Aims: It has been demonstrated that neuroinflammation is associated with cardiovascular dysfunction. The phosphoinositide-3 kinase (PI3K) signaling in the rostral ventrolateral medulla (RVLM), a key region for sympathetic outflow, is upregulated and contributes to increased blood pressure (BP) and sympathetic outflow in hypertension. This study was designed to determine the role of the PI3K signaling in neuroinflammation in the RVLM of hypertension.
| INTRODUCTION
It has been documented that inflammation participates in the development of neurogenic hypertension. 1 The lipopolysaccharide (LPS)-induced systemic inflammation leads to a significant increase in blood pressure (BP). 2 In the RAG-1-/-mice lacking T and B cells, hypertension and abnormal vascular function induced by angiotensin II (Ang II) infusion or deoxycorticosterone acetate-salt are significantly attenuated. 3 It is reported that low-grade inflammation has been detected in peripheral cardiovascular system in hypertensive patients 4 and animals, 5 suggesting that the inflammation is involved in the processing of essential hypertension. The immune inflammatory response in the central nervous system, also called neuroinflammation, is characterized by an increase in the production of proinflammatory cytokines, which is required to activate microglia. 6 It is reported that microinjections of the proinflammatory cytokine interleukin-1β (IL-1β) or tumor necrosis factor-α (TNF-α) into the cardiovascular center paraventricular nucleus (PVN) lead to an increase in BP and renal sympathetic nerve activity (RSNA). 7 Preactivated microglia in the brain has prolonged the pressor response induced by intracerebroventricular injection of Ang II. 8 The rostral ventrolateral medulla (RVLM) has been recognized as a pivotal region for maintaining basal BP and sympathetic tone. 9 The previous evidence indicates that the systemic LPS-induced neuroinflammation in the RVLM is involved in high BP and sympathetic hyperactivity. 2 Therefore, it would be significant to investigate the role of neuroinflammation in the central regulation of cardiovascular function in hypertension, and is helpful for researching for a new strategy against hypertension.
Previous evidence suggests that the phosphoinositide-3 kinase (PI3K) pathway in the RVLM is involved in regulating BP and sympathetic outflow. 10, 11 It has been demonstrated that the PI3K signaling in the RVLM is upregulated in hypertension, and its inactivation leads to reduction in reactive oxygen species (ROS) production and cardiovascular function. 10 Moreover, we recently report that gene knockdown of the PI3K subunit p110δ in the RVLM exerts the centrally antihypertensive action.
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Interestingly, the PI3K signaling is suggested to be involved in several key events in the inflammatory response to damage and infection. 13, 14 Therefore, the major aim of this study was to determine the role of the RVLM PI3K signaling in the neuroinflammation in hypertension.
Overactivity in renin-angiotensin system (RAS) has been shown to play an important role in the pathogenesis of hypertension. 15 and ameliorate the baroreflex function in chronic heart failure. 24 Interestingly, it is reported that Ang-(1-7) has a direct antiinflammatory effect on microglia in vitro. 25 However, it is not clear whether the effect of RAS in the RVLM on neuroinflammation in hypertension is associated with PI3K signaling.
Hence, this study was designed to determine: (i) whether the PI3K gene silencing in the RVLM inhibits neuroinflammation in hypertensive rats; (ii) whether the PI3K silencing in the RVLM attenuates the Ang II-induced high BP and neuroinflammation in WKY rats; and (iii)
whether the PI3K signaling is involved in the antihypertensive effect of ACE2 overexpression by reducing the level of neuroinflammation in the RVLM in hypertensive rats.
| METHODS

| Animals
Sixteen weeks old male SHRs and WKY rats (260-300 g) were used
for this study and purchased from Sino-British SIPPR/BK Laboratory Animal Ltd (Shanghai, China 
| Construction and production of the human ACE2 and PI3K shRNA lentiviral vector
The PI3K shRNA and human (h) ACE2 lentiviral particles were constructed and produced by Shanghai Innovation Biotech (Shanghai, China), as described in our previous studies. 12, 23 In brief, the specific shRNA fragment of rat PI3K p110δ (target sequence: GTAAACGACTTCCGCACTA) was integrated into a pLenR-GPH vector, and the negative fragment (control sequence: TTCTCCGAACGTGTCACGT) was used for the control shRNA. The hACE2 cDNA was amplified through PCR with the use of specific primer (sense 5′-ATGCTGCGCGCCGCACTCAGCAC-3′ and antisense 5′-TTACGAG TTCTTCTGTGGCACTT-3′). Amplified hACE2 cDNA was integrated into pLenO-DCE lentiviral cloning vector, and the pLenO-DCE vector carried a green fluorescent protein (GFP) reporter gene, which acts as control. These two kinds of lentiviral particles were harvested and tested through transfecting 293T cell, and the infectious titer was 5×10 9 transducing units/mL.
| Injections of lentiviral particles into the RVLM
Procedures for microinjection of the lentivirus into the bilateral RVLM were based on the previous study. 23 In brief, rats were fixed in a stereotaxic instrument (Shanghai Alcott Biotech) after anesthetized by inhaling 3% isofluorane. The skull was exposed, and two symmetrical small holes were drilled on the skull surface. According to the atlas of rats, 26 lentiviral particles (250 nL) were slowly injected into the RVLM (2.0 mm lateral to the midline, 3.0 mm posterior to the Lamda, and 10 mm deep to the skull surface) with a 32-gauge Hamilton syringe (5 μL) in 5 minutes. After viral injections, rats were treated with 1000 units of penicillin through muscle injection to prevent infection.
| Intracisternal infusion
To induce neuroinflammation in normotensive WKY rats, intracisternal (fourth ventricle) infusion of Ang II (24 μg/d, 1 week) or LPS (6 μg/d, 2 weeks) was performed by the osmotic minipump, and the infusion doses of agents were based on previous studies. 12, 27 In brief, rats were anesthetized through inhaling 3% isofluorane and placed on the stereotaxic frame. The atlantooccipital membrane was exposed, and the dura was punctured with a needle. After observation of leak- 
| Measurements of BP, HR, and RSNA recording
In conscious rats, the noninvasive tail-cuff system was performed to monitor the systolic BP, diastolic BP, mean arterial pressure (MAP), and heart rate (HR), as described previously. 28 Briefly, conscious rats were restricted by a recording chamber for 15 minutes before measurement of BP to make the rat acclimate the holding device, and to keep rat quiet and comfortable during the whole process. In addition, retaining the ambient temperature of 30°C in chamber with controlled warming plate under the rats is beneficial to vasodilate the tail artery.
Systolic BP (SBP), diastolic BP, mean arterial pressure (MAP), and HR were simultaneously monitored by noninvasive tail-cuff system (ALC-NIBP, Shanghai Alcott Biotech). The values resulted from averaging of at least six consecutive measurements, and BP and HR were measured every week or every 3 days after treatments.
As described previously, 29 levels of BP, HR, and baseline RSNA were also examined in the anesthetized rats after completion of intracisternal infusion. In anaesthetized rats (urethane 800 mg/kg ip and achloralose 40 mg/kg ip), trachea was cannulated and the right femoral artery was catheterized for monitoring BP and HR with the PowerLab system. The left renal sympathetic nerve was isolated retroperitoneally and placed on a pair of silver recording electrodes. The RSNA signal was amplified, integrated, and recorded with the PowerLab system.
Based on previous studies, 29 the maximum of RSNA was measured when rat was euthanized with an overdose of pentobarbital sodium (200 mg/kg). Baseline RSNA was expressed as a percentage of maximal RSNA.
| Western blot analysis
As previously described 30 in brief, after the rats were euthanized with an overdose of pentobarbital sodium (200 mg/kg), the brain was removed quickly and stored in −80°C. The RVLM tissues were punched on a freezing microtome according to the rat atlas, 26 lysed with lysate, and sonicated. The supernatants were collected after centrifugation.
The protein concentration of supernatants was determined by BCA kit, and protein samples were denatured with loading buffer in proportion heating to 100°C for 10 minutes. Protein sample (30 μg) was used to run on a 8% or 12% SDS-PAGE gel and transferred to PVDF membrane, and 5% milk was dissolved in Tris-buffered saline Tween and used to block the membrane; the blocked membranes were incubated with anti-
anti-phospho-AKT (Ser473) (no.4060, CST), anti-AKT (no.9272, CST), and anti-GAPDH (no.sc-47724, Santa Cruz) antibody overnight at 4°C. After three times of washes, species-specific secondary antibodyconjugated horseradish peroxidase was used to interact with epitopespecific primary antibodies in room temperature for 2 hours, and then, the membranes were subjected to chemiluminescent agent for detecting the target protein binding by GeneTools software (Gene Company).
GAPDH served as control to normalize the expression of target proteins.
| Immunofluorescence
As described previously, 23 the fluorescence staining for GFP was detected by laser confocal microscopy. In brief, after the rats were eutha- these sections were then mounted on slides after three 5-min washes and cover-slipped with antifade medium. In addition, the GFP fluorescence was detected by a laser confocal microscopy (Leica, TCS-SP5).
| Detection of proinflammatory cytokines in the RVLM
According to the rat atlas, 26 RVLM tissues were punched, lysed, and sonicated. The supernatants were extracted after centrifugation for detecting proinflammatory cytokines, Ang II/Ang-(1-7), in the RVLM tissues. Finally, the reactions in wells were stopped with Stop Solution. The level of proinflammatory cytokines, Ang II and Ang-(1-7), and the absorbance at 450 nm with an automated microplate reader were determined and were calculated according to the standard curve. 
| Data analysis
| RESULTS
| Gene silencing of the PI3K signaling in the RVLM attenuated neuroinflammation and cardiovascular activity in SHR
As shown in Figure 1A , GFP immunofluorescence staining for lentivirus transfer was expressed restrictedly in the RVLM. Furthermore, transfer efficacy of lentivirus containing specific PI3K p110δ shRNA fragment injected into the RVLM was confirmed by a decrease in expression level of PI3K p110δ protein ( Figure 1B) . It was also observed that the expression level of the RVLM PI3K p110δ was significantly upregulated in SHR compared with WKY rats. As indicated in Figure 1B, ) . Importantly, the levels of IL-1β, IL-6, and TNF-α in the RVLM ( Figure 1C ) and cardiovascular activity under anesthesia (Table 1 ) and conscious state ( Figure 1D ) were significantly decreased in SHR 4 weeks after knockdown of PI3K p110δ
in the RVLM. In additional, injection of lenti-PI3K shRNA into the RVLM had no influence on BP and HR in WKY rats. In order to confirm the role of PI3K in the neuroinflammation induced by Ang II, PI3K shRNA lentivirus was injected into the RVLM before intracisternal infusion of Ang II in WKY rats. As shown in Table 2 Interestingly, the Ang II-induced increases in levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) in the RVLM and cardiovascular activity (BP and HR) were significantly attenuated after pretreatment with silencing of PI3K in the RVLM.
| Gene
| Overexpression of ACE2 inhibited neuroinflammation in the RVLM
As shown in Figure 4A , transfer efficacy of lentivirus containing ACE2 gene (lenti-ACE2) injected into the RVLM was confirmed by an increase in ACE2 protein expression and the ratio of Ang-(1-7) to Ang II in the RVLM. As indicated in Figure 4B , in the GFP group, levels of MAP and HR were significantly (P<.05) increased in conscious WKY rats after treatment with intracisternal infusion of LPS (2 weeks) compared with artificial cerebrospinal fluid (aCSF) infusion. The WKY rats treated with LPS infusion showed a significant increase in baseline RSNA compared with aCSF infusion (Table 3) . Furthermore, the LPSinduced increases in the levels of proinflammatory cytokines (IL-1β, IL-6, and TNF-α) in the RVLM and cardiovascular activity (BP and HR) were significantly attenuated in WKY rat after pretreatment with ACE2 overexpression in the RVLM. Moreover, intracisternal infusion of LPS (2 weeks) significantly upregulated the expression level of p110δ subunit of PI3K and AKT phosphorylation at Ser473 in the RVLM of WKY rats, which was prevented by overexpression of ACE2.
In SHR, it was observed that SHR showed a significant decrease in BP, HR, and basal RSNA 4 weeks after ACE2 overexpression in the RVLM (Table 4) It has been demonstrated that the proinflammatory cytokines produced by microglia in the brain increase sympathetic outflow, which is relative to the development of hypertension. 31 In this study, we confirmed that the level of proinflammatory cytokines in the RVLM was increased in SHR; silencing PI3K signaling in the RVLM attenuated the T A B L E 1 Levels of BP, HR, and RSNA in the anesthetized WKY and SHR rats 4 wk after PI3K shRNA injected into the RVLM is significantly increased and contributes to sympathetic overactivity in hypertension and chronic heart failure. 32, 33 The previous study has suggested that the Ang II activates the T-cell RAS leading to amplified low-grade inflammation in hypertensive patients. 34 Blockade of AT1R inhibits the acute inflammatory response induced by LPS treatment in vitro and in vivo. 16 Therefore, these observations lead to a possibility that PI3K signaling is involved in neuroinflammation, which mediates the sympathoexcitation and hypertension in central Ang II-induced hypertensive rats and SHR.
Another finding in the present study is that overexpression of For example, it is reported that Ang-(1-7) prevents the radiationinduced inflammation in rat primary astrocyte via inhibiting the activation of MAP kinase signaling. 36 In a vitro study, Ang-(1-7) decreases significantly the basal level of the proinflammatory cytokines in primary microglial cells, suggesting that Ang-(1-7) exerts a direct antiinflammatory effect on microglia. 25 In this work, gene transfer of ACE2
in the RVLM was confirmed by increases in ACE2 protein expression and ratio of Ang1-7/AngII content in the RVLM. In addition, it is found that GPF is expressed in both neurons and microglia in the RVLM after gene transfer. Therefore, it is possible that functional state of both neurons and microglia contributes to beneficial effect of the RVLM ACE2 on hypertension. Importantly, the current data revealed that pretreatment with ACE2 overexpression in the RVLM significantly attenuated the LPS-induced increase in BP, RSNA, and proinflammatory overexpression. These findings suggest that antiinflammation plays an important role in mediating the beneficial effects of central ACE2 on hypertension.
In this study, the major finding was to also confirm the impor- It is reported that the activity of the PI3K/AKT pathway is enhanced in the RVLM of SHR, 10 and the phosphorylation of AKT in the PVN of hypertensive rats is also increased. 38 Recently, we also confirmed that an inactivation of PI3K signaling in the RVLM is involved in antioxidative stress induced by central antihypertensive mechanism. 12 However, the present data does not address the question how ACE2 reduces the production of proinflammatory cytokines via an inactivation of PI3K signaling. It is well known that nuclear factor-kappa B (NF-κB) plays an important role in production of proinflammatory cytokines. Chronic Ang-(1-7) treatment pathways. 40 Interestingly, it also has been reported that ACE2 prevents the LPS-induced inflammation via inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium. 41 Therefore, it is possible that increase in endogenous Ang-(1-7) by ACE2 overexpression inhibits the PI3K/AKT-mediated NF-κB activation, in turn which reduces the production of proinflammatory cytokines and neuroinflammation.
| CONCLUSION
The current results suggest that both neuroinflammation and cardio- 
